FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Samuel Yu

Research Profile

Procedures

Living Beings

Physiology

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
Julie A Margenthaler; Samuel Yu; Naoki Otomo; Manfred Lehmann; M Wayne Flye
Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft.
Julie A Margenthaler; F Tu; Naoki Otomo; Yoshiaki Shimizu; Samuel Yu; M Wayne Flye
Immunogenicity of L(d+) transgenic mouse hearts.
Julie A Margenthaler; Naoki Otomo; Yoshiaki Shimizu; Samuel Yu; M Wayne Flye
Delayed type hypersensitivity in the CD8+ dominant anti-class I L(d) alloantigen 2C transgenic mouse is mediated by small but significant CD4 population.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Samuel Yu (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2003: Julie A Margenthaler; Samuel Yu; Naoki Otomo; Manfred Lehmann; M Wayne Flye
Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft.
Transplant international : official journal of the European Society for Organ Transplantation 2003;16(10):713-20.
2001: Julie A Margenthaler; F Tu; Naoki Otomo; Yoshiaki Shimizu; Samuel Yu; M Wayne Flye
Immunogenicity of L(d+) transgenic mouse hearts.
Surgery 2001;130(2):217-24.
2001: Julie A Margenthaler; Naoki Otomo; Yoshiaki Shimizu; Samuel Yu; M Wayne Flye
Delayed type hypersensitivity in the CD8+ dominant anti-class I L(d) alloantigen 2C transgenic mouse is mediated by small but significant CD4 population.
Transplantation proceedings 2001;33(1-2):338-9.
2001: Naoki Otomo; K Motoyama; Samuel Yu; Yoshiaki Shimizu; Julie A Margenthaler; F Tu; M Wayne Flye
Intrathymic alloantigen-mediated tolerant, completely MHC-mismatched mouse hearts are specifically rejected by adoptively transferred in vitro-sensitized anti-class I L(d+)-specific 2C cells.
Transplantation proceedings 2001;33(1-2):159-60.
2001: Yoshiaki Shimizu; Naoki Otomo; Samuel Yu; Julie A Margenthaler; M Wayne Flye
Donor-specific antigen transfusion-mediated cardiac allograft tolerance is prevented by prior treatment with anti-CD8, but not anti-CD4, antibody.
Transplantation proceedings 2001;33(1-2):150-1.
2001: Julie A Margenthaler; Samuel Yu; Naoki Otomo; Yoshiaki Shimizu; M Wayne Flye
Portal venous tolerance in the anti-class I L(d) alloantigen 2C transgenic mouse.
Transplantation proceedings 2001;33(1-2):143-4.
2000: Naoki Otomo; K Motoyama; Samuel Yu; Yoshiaki Shimizu; Julie A Margenthaler; F Tu; M Wayne Flye
Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
Surgery 2000;128(2):206-12.
2000: Craig R Smith; Thalachallour Mohanakumar; Yoshiaki Shimizu; Samuel Yu; Naoki Otomo; Zahid Kaleem; M Wayne Flye
Brief cyclosporine treatment prevents intrathymic (IT) tolerance induction and precipitates acute rejection in an IT rat cardiac allograft model.
Transplantation 2000;69(2):294-9.
2000: K Motoyama; T Arima; Samuel Yu; Manfred Lehmann; M Wayne Flye
The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration.
Transplantation 2000;69(2):285-93.
1997: Samuel Yu; Y Nakafusa; M Wayne Flye
In vitro analysis of gadolinium chloride abrogation of the systemic tolerance induced by portal venous administration of ultraviolet B-irradiated donor cells.
Transplantation 1997;64(12):1684-8.